ArticleRadiology. Imaging cancer2025
MRI-based Intra- and Peritumoral Heterogeneity in Hepatocellular Carcinoma for Microvascular Invasion Prediction and Prognostic Risk Stratification.
Article in Radiology. Imaging cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Transformer-Based Multitask Framework Integrating Habitat and Deep Learning for Predicting Early Disease Control and Survival in Immunotherapy-Treated Hepatocellular Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Multi-habitat radiomics on T2-FS MRI for identifying spatial patterns of axial spondyloarthritis-associated bone marrow edema.Clinical rheumatology · 2026Article
- CT-based habitat analysis combined with multi-channel deep learning for predicting early recurrence after pancreatic cancer resection: a multicenter study.Journal of translational medicine · 2026Article
- Habitat-Based Radiomics for Predicting Visceral Pleural Invasion in Subpleural Nodules with Solid Component on Low-Dose CT: A Multicenter Study.Diagnostics (Basel, Switzerland) · 2026Article
- From Tumor to Tumor-Spleen: MRI Habitat Heterogeneity for Predicting Immunotherapy Outcome in Advanced Hepatocellular Carcinoma.Journal of hepatocellular carcinoma · 2026Article
- Preoperative Prediction of TACE Refractoriness in Hepatocellular Carcinoma Using CT-Based Radiomics Model.Journal of hepatocellular carcinoma · 2026Article
- CT-based habitat imaging integrated with radiomics and clinicopathology for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To evaluate an MRI-based strategy for quantifying intra- and peritumoral heterogeneity (ITH and PTH) in hepatocellular carcinoma (HCC) and develop ITH- and PTH-based models for diagnosing microvascular invasion (MVI) and stratifying prognostic risk. Materials and Methods Patients with HCC (≤5 cm) were retrospectively included from three different institutions from March 2012 to September 2023 and divided into internal training, internal testing, and external testing cohorts. Tumor and peritumoral tissues in MR images were categorized into distinct habitats using unsupervised clustering algorithms. High-throughput radiomic features were extracted from each habitat. The degree of feature variation within each habitat was quantified to derive characteristics representing ITH and PTH. Engineered features were developed to train machine learning models for MVI diagnosis. Kaplan-Meier survival curves and Cox regression analysis were used for survival analysis. Results A total of 432 patients (mean age, 54.31 years ± 11.15 [SD]; 371 male) were included. The TH_DNN model, constructed using ITH- and PTH-based quantitative features combined with a deep neural network (DNN), demonstrated the best predictive performance for MVI across the three datasets (area under the receiver operating characteristic curve range = 0.82-0.99). The subgroup predicted as MVI positive with the TH_DNN model exhibited a poorer prognosis than the MVI-negative subgroup. In terms of overall survival and postoperative recurrence, the hazard ratios for MVI diagnosis were 2.79 (95% CI: 1.35, 5.75;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.